Epsilon M&A Deal Report - Laboratories Filorga Cosmetiques
Transaction Multiples for the Valuation of Private Companies
Colgate-Palmolive / Laboratories Filorga Cosmetiques
No EMAT :
95502
Announced Date :
11/07/2019
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Colgate-Palmolive
Target :
Laboratories Filorga Cosmetiques
Country :
Paris
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
Business Description :
Founded in 1978, Laboratoires Filorga provides medical anti-ageing cosmetics for medical professions and general consumers in France and internationally. > Offers anti-ageing cosmetics for wrinkles,...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Personal Products » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 21/01/2019 | Private group led by Idia Capital Investissement, Amundi Private Equity Funds, Socadif and Andera Partners (ActoMezz) | Bioclinic (SELAS BIO-CLINIC) | Hauts-De-Seine | * | 94685 |
| 01/02/2018 | Private Group led by Axcel Management | Invima (Isadora) | Sweden | * | 94545 |
Source: Epsilon Research / EMAT
